statements

Centenial Surgical Suture Ltd.

BSE: 531380

Sector: Healthcare

Industry Group: Healthcare Equipment & Supplies

Industry: Medical Equipment & Supplies

85.00+3.4 (+4.13%)

7 Aug, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Centenial Surgical Suture Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	52.75	56.05	55.61	36.93	44.43	52.66	51.19	53.52	53.84
Cost of Operating Revenue	24.55	25.73	25.84	11.92	21.18	21.37	18.45	21.48	22.75
Gross Profit	28.19	30.33	29.77	25.02	23.25	31.29	32.74	32.03	31.09
Gross Margin	53.4	54.1	53.5	67.7	52.3	59.4	64.0	59.9	57.8
Total Operating Expenses	48.89	51.47	51.28	33.39	41.46	49.53	47.45	51.39	52.58
Operating Profit	3.85	4.59	4.34	3.55	2.97	3.13	3.74	2.13	1.26
Operating Margin	7.3	8.2	7.8	9.6	6.7	5.9	7.3	4.0	2.3
Financing Income/(Expense) - Net	-1.20	-1.51	-1.15	-1.05	-1.89	-0.96	-1.54	-1.56	-3.34
Profit before Taxes	2.41	2.84	2.16	1.53	1.07	1.46	1.27	-1.62	-2.08
Income Taxes	0.87	0.83	0.86	0.57	0.45	0.58	0.14	-0.15	0.12
Profit after Tax	1.54	2.02	1.30	0.96	-	0.89	1.13	-1.46	-2.20
PAT Margin	2.9	3.6	2.3	2.6	-	1.7	2.2	-2.7	-4.1
EPS - Basic - ex Extraordinary Items	4.23	5.53	3.55	2.64	-	2.43	3.11	-4.01	-6.04
EPS - Diluted - ex Extraordinary Items	4.23	5.53	3.55	2.64	-	2.43	3.11	-4.01	-6.04
EBIT	3.85	4.59	4.34	3.55	2.97	3.13	3.74	2.13	1.26
EBITDA	4.45	5.28	5.89	5.10	4.49	4.43	5.13	6.38	5.26
EBITDA Margin	8.4	9.4	10.6	13.8	10.1	8.4	10.0	11.9	9.8

Balance Sheet

Abridged

Understanding Balance Sheet

Centenial Surgical Suture Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	51.22	52.19	57.67	60.61	53.27	59.37	65.32	62.96	60.03
Long-Term Investments	0.16	0.21	0.31	0.31	0.33	0.36	0.47	0.47	0.53
Property Plant & Equipment - Net	4.02	4.29	10.65	8.97	7.60	6.46	12.77	19.98	18.21
Total Non-Current Assets	4.17	4.57	11.15	9.43	8.07	7.03	13.83	21.62	19.76
Total Assets	55.39	56.76	68.82	70.05	61.34	66.40	79.15	84.58	79.79
Total Current Liabilities	26.54	26.11	30.69	31.50	24.27	29.07	32.85	31.83	31.57
Long Term Debt	1.20	1.20	7.92	6.88	-	4.36	12.30	20.40	-
Total Non-Current Liabilities	2.81	2.60	9.52	8.97	6.87	6.24	14.08	22.00	19.67
Total Liabilities	29.35	28.71	40.21	40.47	31.14	35.32	46.93	53.83	51.24
Total Shareholders' Equity	26.04	28.06	28.61	29.57	30.20	31.08	32.22	30.75	28.55
Total Equity	26.04	28.06	28.61	29.57	30.20	31.08	32.22	30.75	28.55
Total Liabilities & Equity	55.39	56.76	68.82	70.05	61.34	66.40	79.15	84.58	79.79

Cash Flow

Abridged

Understanding Cash Flow Statement

Centenial Surgical Suture Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	3.01	3.54	3.31	3.08	4.50	2.76	2.66	2.64	1.92
Working Capital - Increase/(Decrease)	-1.18	-2.03	-1.48	-3.18	0.25	-3.15	0.86	10.55	1.84
Net CF from Operating Activities	1.83	1.51	1.83	-0.10	2.85	-0.38	3.52	13.19	3.76
Capital Expenditures - Net	0.71	0.98	1.08	0.84	0.16	0.16	7.70	11.47	2.23
Net CF from Investing Activities	-0.71	-0.98	-1.06	-0.84	-0.16	-0.16	-7.70	-11.47	-2.23
Debt - LT & ST - Issuance/(Retirement) - Total	-0.88	-1.27	-0.37	0.75	-2.97	0.62	4.53	-2.19	-1.55
Net Cash Flow from Financing Activities	-0.88	-1.27	-0.37	0.75	-2.97	0.62	4.53	-2.19	-1.55
Free Cash Flow to Equity	0.24	-0.75	0.38	-0.18	-0.28	0.07	0.35	-0.47	-0.02
Free Operating CF net dividend	1.12	0.53	0.75	-0.94	2.69	-0.54	-4.17	1.72	1.53
Free Operating CF	1.12	0.53	0.75	-0.94	2.69	-0.54	-4.17	1.72	1.53

Business Segment Analysis

Centenial Surgical Suture Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Centenial Surgical Suture Ltd.

Regional Segment Analysis

Centenial Surgical Suture Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Centenial Surgical Suture Ltd.

Historical Segment Analysis

Track how Centenial Surgical Suture Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Centenial Surgical Suture Ltd.

Frequently Asked Questions

What is the revenue of Centenial Surgical Suture Ltd.?

The latest trailing twelve month revenue of Centenial Surgical Suture Ltd. is ₹ 53.84 Cr, reflecting a 1-year growth of 0.61% and a 3-year CAGR of 0.74%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Centenial Surgical Suture Ltd.?

The latest trailing twelve month net profit (PAT) of Centenial Surgical Suture Ltd. is ₹ -2.20 Cr, with a 3-year earnings CAGR of -64.94%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Centenial Surgical Suture Ltd.?

The trailing twelve month EBITDA of Centenial Surgical Suture Ltd. is approximately ₹ 1.26 Cr (based on an operating margin of 2.34%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Centenial Surgical Suture Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Centenial Surgical Suture Ltd. is -6.04. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Centenial Surgical Suture Ltd.?

The debt-to-equity ratio of Centenial Surgical Suture Ltd. stands at 0.38. The interest coverage ratio is 0.38x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Centenial Surgical Suture Ltd.?

The estimated book value per share of Centenial Surgical Suture Ltd. is 78.26 (derived from a P/B ratio of 1.09 and market price of ₹ 85.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Centenial Surgical Suture Ltd.?

The trailing twelve month operating cash flow of Centenial Surgical Suture Ltd. is ₹ 3.76 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Centenial Surgical Suture Ltd. report consolidated or standalone financials?

Centenial Surgical Suture Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.